Bo Zhou

Bo Zhou, MSc, PhD, has extensive work experience in the pharmaceutical industry. From 2018 to 2021, they held the position of Head of Pharmaceutical Product Development at Zogenix, Inc., which was later acquired by UCB. In 2021, they moved on to become the Head of Pharmaceutical Product Development and Manufacturing, Senior Director at Neumora.

Bo Zhou, MSc, PhD has pursued their education at various prestigious institutions. Bo completed their PhD in Industrial and Physical Pharmacy at Purdue University. Prior to that, they obtained their MS in Biological Engineering from the same university. Bo Zhou further enhanced their knowledge and skills by participating in executive education at the Stanford University Graduate School of Business. Bo also completed extension programs at the University of California, Berkeley. Additionally, they engaged with the Purdue University Daniels School of Business, however, the specific degree and field of study remain unknown.